David H. Epstein mainly focuses on Psychiatry, Clinical psychology, Addiction, Heroin and Craving. His study in the fields of Methadone and Relapse prevention under the domain of Psychiatry overlaps with other disciplines such as Physical dependence. His research investigates the link between Clinical psychology and topics such as Affect that cross with problems in Physical disorder.
David H. Epstein interconnects Cognition and Substance abuse in the investigation of issues within Addiction. His work in Heroin addresses issues such as Abstinence, which are connected to fields such as Anesthesia and Self-administration. His Craving study integrates concerns from other disciplines, such as Young adult and Drug.
David H. Epstein focuses on Psychiatry, Methadone, Heroin, Craving and Abstinence. The concepts of his Psychiatry study are interwoven with issues in Young adult and Clinical trial. In general Methadone study, his work on Methadone maintenance often relates to the realm of Opioid use disorder, thereby connecting several areas of interest.
As part of one scientific family, David H. Epstein deals mainly with the area of Heroin, narrowing it down to issues related to the Randomized controlled trial, and often Confidence interval. His biological study spans a wide range of topics, including Incubation, Drug and Clinical psychology, Mood. His work deals with themes such as Relapse prevention and Self-administration, which intersect with Abstinence.
David H. Epstein mostly deals with Opioid use disorder, Methadone, Craving, Addiction and Clinical psychology. His Craving research includes elements of Coping and Cannabis. His Addiction research is multidisciplinary, incorporating perspectives in Psychotherapist, Compulsive behavior and Mood.
Mood is a subfield of Psychiatry that David H. Epstein explores. His Clinical psychology research integrates issues from Experience sampling method, Psychosocial, Cannabidiol, Anxiety and Abstinence. The study incorporates disciplines such as Incubation, Relapse prevention and Drug in addition to Abstinence.
His primary areas of study are Methadone, Buprenorphine, Opioid use disorder, Context and Gps data. The Buprenorphine study combines topics in areas such as μ-opioid receptor and Oxycodone. While the research belongs to areas of Physical therapy, David H. Epstein spends his time largely on the problem of Clinical trial, intersecting his research to questions surrounding Addiction.
His Addiction research is multidisciplinary, relying on both Drug access, Placebo and Contingency management. His Predictive value study typically links adjacent topics like Craving. David H. Epstein interconnects Clinical psychology and Mood in the investigation of issues within Craving.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure.
David H. Epstein;David H. Epstein;Kenzie L. Preston;Jane Stewart;Yavin Shaham.
A Memory Retrieval-Extinction Procedure to Prevent Drug Craving and Relapse
Yan-Xue Xue;Yi-Xiao Luo;Ping Wu;Hai-Shui Shi;Hai-Shui Shi.
Opiate versus psychostimulant addiction: the differences do matter
Aldo Badiani;David Belin;David Epstein;Donna Calu.
Nature Reviews Neuroscience (2011)
Real-time electronic-diary reports of cue exposure and mood in the hours before cocaine and heroin craving and use
David H. Epstein;Jessica Willner-Reid;Massoud Vahabzadeh;Mustapha Mezghanni.
Archives of General Psychiatry (2009)
Neurobiology of relapse to heroin and cocaine seeking: an update and clinical implications.
Jennifer M. Bossert;Udi E. Ghitza;Lin Lu;David H. Epstein.
European Journal of Pharmacology (2005)
Cognitive-behavioral therapy plus contingency management for cocaine use: findings during treatment and across 12-month follow-up.
David H. Epstein;Wesley E. Hawkins;Lino Covi;Annie Umbricht.
Psychology of Addictive Behaviors (2003)
Time to connect: bringing social context into addiction neuroscience
Markus Heilig;David H. Epstein;Michael A. Nader;Yavin Shaham.
Nature Reviews Neuroscience (2016)
Incubation of Cue-Induced Cigarette Craving During Abstinence in Human Smokers
Gillinder Bedi;Gillinder Bedi;Kenzie L. Preston;David H. Epstein;Stephen J. Heishman.
Biological Psychiatry (2011)
Volitional social interaction prevents drug addiction in rat models.
Marco Venniro;Michelle Zhang;Daniele Caprioli;Jennifer K. Hoots.
Nature Neuroscience (2018)
The Fagerstrom Test for Nicotine Dependence and the Diagnostic Interview Schedule: Do they diagnose the same smokers?
Eric T Moolchan;Aleksandras Radzius;David H Epstein;George Uhl.
Addictive Behaviors (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: